Reaction
Mallory-Weiss Syndrome reporting signals
As of the last recalculation, Mallory-Weiss Syndrome appears in 1,254 FAERS reports alongside 13 co-occurring drug terms. The strongest observed disproportionality signal is DIMENHYDRINATE (PRR 20.5).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Dimenhydrinate | 13 | 20.5 | 20.5 |
| Clopidogrel Bisulfate | 81 | 14.0 | 14.0 |
| Warfarin Sodium | 33 | 12.1 | 12.1 |
| Rivaroxaban | 131 | 11.5 | 11.6 |
| Clopidogrel | 122 | 11.2 | 11.2 |
| Apixaban | 34 | 8.6 | 8.6 |
| Pemetrexed | 11 | 8.6 | 8.6 |
| Prasugrel Hydrochloride | 4 | 6.6 | 6.6 |
| Methoxy Polyethylene Glycol-Epoetin Beta | 4 | 6.0 | 6.0 |
| Dabigatran Etexilate | 27 | 5.9 | 5.9 |
| Lurasidone Hydrochloride | 7 | 5.6 | 5.6 |
| Dasatinib | 12 | 5.4 | 5.4 |
| Velpatasvir And Sofosbuvir | 3 | 3.9 | 3.9 |